跳至主要内容
临床试验/EUCTR2011-001132-30-CZ
EUCTR2011-001132-30-CZ进行中(未招募)1 期

on-invasive parameters in the evaluation of portal hypertension in patients with liver cirrhosis and their significance for the evolution of cardial complications.

Všeobecná fakultní nemocnice v Praze0 个研究点目标入组 100 人开始时间: 2011年4月14日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Liver cirrhosis with portal hypertension and esophageal varices
  • Indication for treatment with betablockers in the prevention of variceal bleeding
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Hepatocellular carcinoma
  • Advanced liver failure (Child-Pugh more than 13 points)
  • Contraindication to carvedilol:
  • Decompensated hearth failureNYHA IV
  • Known sensitivity to carvedilol or vehicules
  • Astma bronchiale
  • A-V block 2-3. degree
  • Severe bradycardie (under 50 beats/min)
  • Cardiogenic shock
  • Sick-sinus syndrom
  • Severe hypotension (systolic BP under 85 mm Hg)
  • Portosystemic shunt
  • Portal vein thrombosis
  • Gravidity or lactation
  • Age under 18 years

研究者

相似试验

The usefullness of non-invasive parameters in the... | 临床试验